NCT04695028 CRYSTALILLE Cohort: Getting the Whole Picture of Crystal-related Arthropathies
| NCT ID | NCT04695028 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lille Catholic University |
| Condition | Gout |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2021-03-16 |
| Primary Completion | 2023-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2021-03-16 with a primary completion date of 2023-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this research is to collect data to create an observatory of microcrystalline rheumatism (gout and calcium-crystal rheumatism) in patients treated at the Groupement des Hôpitaux de l'Institut Catholique de Lille, in order to better understand the disease and improve patient care, in particular with the help of medical imaging.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of gout according to American College of Rheumatology /European League Against Rheumatism (ACR/EULAR) 2015 criteria OR diagnosis of calcium pyrophosphate dihydrate crystal deposition disease (CPPD) based on EULAR 2011 recommendations OR diagnosis of hydroxyapatite crystal rheumatism (HCR) according to a typical clinical sequence and demonstration of compatible calcium deposits on imaging * patient who will benefit or has benefited from an ultrasound and/or DECT evaluation of microcrystalline deposits * clinical suspicion of microcrystalline rheumatism requiring further imaging to confirm the diagnosis Exclusion Criteria: * Refusal or contra-indication to perform ultrasound or dual energy scanning. * Patient's opposition to the use of his or her health data for research purposes * Patient under guardianship or curatorship * Pregnant woman * Person not affiliated to a social security scheme or entitled to a social security benefit
Contact & Investigator
Tristan Pascart, MD
PRINCIPAL INVESTIGATOR
GHICL
Frequently Asked Questions
Who can join the NCT04695028 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gout. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04695028 currently recruiting?
Yes, NCT04695028 is actively recruiting participants. Contact the research team at lebitasy.marie-paule@ghicl.net for enrollment information.
Where is the NCT04695028 trial being conducted?
This trial is being conducted at Lomme, France.
Who is sponsoring the NCT04695028 clinical trial?
NCT04695028 is sponsored by Lille Catholic University. The principal investigator is Tristan Pascart, MD at GHICL. The trial plans to enroll 1,000 participants.